Search Results - N. A. Bezdenezhnykh

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1

    PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1 by N. A. Bezdenezhnykh, A. N. Sumin, O. L. Barbarash

    Published 2017-05-01

    The review presents current data on the prevalence of diabetes in the cohort of patients undergoing coronary artery bypass grafting and percutaneous coronary intervention. The expediency of a proactive approach to identifying diabetes and pre-diabetes in patients with coronary heart disease before c...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    DIABETES PATIENT AND MYOCARDIAL REVASCULARIZATION FROM THE EVIDENCE GUIDED PERSPECTIVE: CARDIOLOGIST OPINION. PART 2

    DIABETES PATIENT AND MYOCARDIAL REVASCULARIZATION FROM THE EVIDENCE GUIDED PERSPECTIVE: CARDIOLOGIST OPINION. PART 2 by N. A. Bezdenezhnykh, A. N. Sumin, O. L. Barbarash

    Published 2017-06-01

    The review focuses on the recent state of the prescription problem of glucose lowering medications in perioperational period for myocardial revascularization in diabetes patients. The positions provided, from current clinical guidelines of the main societies on diabetes and cardiovascular diseases i...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    RISK FACTORS OF MAJOR CARDIOVASCULAR EVENTS IN LONG-TERM PERIOD OF CORONARY BYPASS IN PATIENTS WITH ISCHEMIC HEART DISEASE AND 2ND TYPE DIABETES MELLITUS

    RISK FACTORS OF MAJOR CARDIOVASCULAR EVENTS IN LONG-TERM PERIOD OF CORONARY BYPASS IN PATIENTS WITH ISCHEMIC HEART DISEASE AND 2ND TYPE DIABETES MELLITUS by A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash

    Published 2015-06-01

    Aim. To reveal the risk factors of major cardiovascular events (MCVE) in long-term period after CABG with DM2.Material and methods. Prospective study of 324 patients with CHD after CABG. Patients were selected into 2 groups: 148 with DM2 (median age 58 y., median of long-term follow-up 1,8 y.), 176...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting

    Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting by A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash

    Published 2018-11-01

    Aim. To assess  the  relationship between pre-diabetes/type 2 diabetes mellitus (type 2 DM) and  long-term adverse  prognosis in patients with coronary  artery disease (CAD) who underwent coronary  artery bypass grafting (CABG).Material and methods. 347 CAD patients who underwent CABG in the period...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Renal function and non-coronary atherosclerosis progression in patients with coronary artery disease one year after coronary artery bypass

    Renal function and non-coronary atherosclerosis progression in patients with coronary artery disease one year after coronary artery bypass by A. V. Bezdenezhnykh, A. N. Sumin, N. A. Bezdenezhnykh, Ya. V. Kazachek, O. L. Barbarash

    Published 2019-04-01

    Aim. To study associations of the estimated glomerular filtration rate (eGFR) with non-coronary atherosclerosis progression criteria and risk factors one year after coronary bypass surgery (CABG).Material and methods. Of the 732 patients consecutively operated (586 men and 146 women, median age 59 y...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    LUNG DIFFUSION CAPACITY AND NON-SPECIFIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS

    LUNG DIFFUSION CAPACITY AND NON-SPECIFIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS by E. D. Bazdyrev, Yu. V. Bayrakova, O. M. Polikutina, N. A. Bezdenezhnykh, Yu S. Slepynina, O. L. Barbarash

    Published 2013-12-01

    Aim. To assess the differences in the lung diffusion capacity and non-specific inflammation markers among patients with coronary heart disease (CHD) and the combination of CHD and Type 2 diabetes mellitus (DM-2). Material and methods. The study included 70 CHD patients: with DM-2 (n=40; 57,1%) and w...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    PRE-SURGERY STATUS AND IN-HOSPITAL COMPLICATIONS OF CORONARY BYPASS GRAFTING IN PREDIABETES AND TYPE 2 DIABETES PATIENTS

    PRE-SURGERY STATUS AND IN-HOSPITAL COMPLICATIONS OF CORONARY BYPASS GRAFTING IN PREDIABETES AND TYPE 2 DIABETES PATIENTS by A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, A. V. Osokina, A. A. Kuzmina, О. V. Gruzdeva, О. L. Barbarash

    Published 2018-06-01

    Aim. Investigation of pre-operational status and the rate of in-hospital complications of coronary bypass surgery in patients with prediabetes comparing to diabetes type 2 (DM2) and normoglycemia.Material and methods. Totally, 708 consecutive patients included, post coronary bypass grafting (CBG) in...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: